These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12695513)

  • 1. Differential degradation of amyloid beta genetic variants associated with hereditary dementia or stroke by insulin-degrading enzyme.
    Morelli L; Llovera R; Gonzalez SA; Affranchino JL; Prelli F; Frangione B; Ghiso J; Castano EM
    J Biol Chem; 2003 Jun; 278(26):23221-6. PubMed ID: 12695513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggregation and catabolism of disease-associated intra-Abeta mutations: reduced proteolysis of AbetaA21G by neprilysin.
    Betts V; Leissring MA; Dolios G; Wang R; Selkoe DJ; Walsh DM
    Neurobiol Dis; 2008 Sep; 31(3):442-50. PubMed ID: 18602473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-degrading enzyme in brain microvessels: proteolysis of amyloid {beta} vasculotropic variants and reduced activity in cerebral amyloid angiopathy.
    Morelli L; Llovera RE; Mathov I; Lue LF; Frangione B; Ghiso J; Castaño EM
    J Biol Chem; 2004 Dec; 279(53):56004-13. PubMed ID: 15489232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotoxicity and physicochemical properties of Abeta mutant peptides from cerebral amyloid angiopathy: implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease.
    Murakami K; Irie K; Morimoto A; Ohigashi H; Shindo M; Nagao M; Shimizu T; Shirasawa T
    J Biol Chem; 2003 Nov; 278(46):46179-87. PubMed ID: 12944403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation of Alzheimer's Amyloid-β by a Catalytically Inactive Insulin-Degrading Enzyme.
    Sahoo BR; Panda PK; Liang W; Tang WJ; Ahuja R; Ramamoorthy A
    J Mol Biol; 2021 Jun; 433(13):166993. PubMed ID: 33865867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purified recombinant insulin-degrading enzyme degrades amyloid beta-protein but does not promote its oligomerization.
    Chesneau V; Vekrellis K; Rosner MR; Selkoe DJ
    Biochem J; 2000 Oct; 351 Pt 2(Pt 2):509-16. PubMed ID: 11023838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The catalytic domain of insulin-degrading enzyme forms a denaturant-resistant complex with amyloid beta peptide: implications for Alzheimer disease pathogenesis.
    Llovera RE; de Tullio M; Alonso LG; Leissring MA; Kaufman SB; Roher AE; de Prat Gay G; Morelli L; Castaño EM
    J Biol Chem; 2008 Jun; 283(25):17039-48. PubMed ID: 18411275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme.
    Vekrellis K; Ye Z; Qiu WQ; Walsh D; Hartley D; Chesneau V; Rosner MR; Selkoe DJ
    J Neurosci; 2000 Mar; 20(5):1657-65. PubMed ID: 10684867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulysin hydrolyzes amyloid beta peptides to products that are neither neurotoxic nor deposit on amyloid plaques.
    Mukherjee A; Song E; Kihiko-Ehmann M; Goodman JP; Pyrek JS; Estus S; Hersh LB
    J Neurosci; 2000 Dec; 20(23):8745-9. PubMed ID: 11102481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains.
    Pérez A; Morelli L; Cresto JC; Castaño EM
    Neurochem Res; 2000 Feb; 25(2):247-55. PubMed ID: 10786709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic effects of D23N Iowa mutant amyloid beta -protein.
    Van Nostrand WE; Melchor JP; Cho HS; Greenberg SM; Rebeck GW
    J Biol Chem; 2001 Aug; 276(35):32860-6. PubMed ID: 11441013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolytically inactive insulin-degrading enzyme inhibits amyloid formation yielding non-neurotoxic aβ peptide aggregates.
    de Tullio MB; Castelletto V; Hamley IW; Martino Adami PV; Morelli L; Castaño EM
    PLoS One; 2013; 8(4):e59113. PubMed ID: 23593132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation.
    Qiu WQ; Walsh DM; Ye Z; Vekrellis K; Zhang J; Podlisny MB; Rosner MR; Safavi A; Hersh LB; Selkoe DJ
    J Biol Chem; 1998 Dec; 273(49):32730-8. PubMed ID: 9830016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
    Farris W; Mansourian S; Chang Y; Lindsley L; Eckman EA; Frosch MP; Eckman CB; Tanzi RE; Selkoe DJ; Guenette S
    Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4162-7. PubMed ID: 12634421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin: a novel substrate and a modulator of insulin-degrading enzyme activity.
    Ciaccio C; Tundo GR; Grasso G; Spoto G; Marasco D; Ruvo M; Gioia M; Rizzarelli E; Coletta M
    J Mol Biol; 2009 Feb; 385(5):1556-67. PubMed ID: 19073193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis for the recognition and cleavages of IGF-II, TGF-alpha, and amylin by human insulin-degrading enzyme.
    Guo Q; Manolopoulou M; Bian Y; Schilling AB; Tang WJ
    J Mol Biol; 2010 Jan; 395(2):430-43. PubMed ID: 19896952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, aggregation, neurotoxicity, and secondary structure of various A beta 1-42 mutants of familial Alzheimer's disease at positions 21-23.
    Murakami K; Irie K; Morimoto A; Ohigashi H; Shindo M; Nagao M; Shimizu T; Shirasawa T
    Biochem Biophys Res Commun; 2002 May; 294(1):5-10. PubMed ID: 12054732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A capillary electrophoresis method for evaluation of Abeta proteolysis in vitro.
    Alper BJ; Schmidt WK
    J Neurosci Methods; 2009 Mar; 178(1):40-5. PubMed ID: 19071160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eicosapentaenoic acid and docosahexaenoic acid increase the degradation of amyloid-β by affecting insulin-degrading enzyme.
    Grimm MO; Mett J; Stahlmann CP; Haupenthal VJ; Blümel T; Stötzel H; Grimm HS; Hartmann T
    Biochem Cell Biol; 2016 Dec; 94(6):534-542. PubMed ID: 27813426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-degrading enzyme degrades amyloid peptides associated with British and Danish familial dementia.
    Morelli L; Llovera RE; Alonso LG; Frangione B; de Prat-Gay G; Ghiso J; Castaño EM
    Biochem Biophys Res Commun; 2005 Jul; 332(3):808-16. PubMed ID: 15913558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.